Prepared remarks
Good morning, everyone. I'm delighted to welcome you to our 2024 Preliminary Results Presentation. With me this morning is Soraya Benchikh, CFO, and Victoria Buxton, Group Head of Investors Relations. I will begin with our transformation highlights and the progress we have made during our investment year. Soraya will then take you through our financial results in more detail before I return to talk more about our performance outlook ahead of Q&A. With that, I would like to draw your attention to the disclaimers on Slide 2 and 3. Let's begin by looking at the positive transformation momentum we are driving, starting with some highlights. 2024 was a key moment in our transformation journey as we sharpened our execution, enabling us to navigate near-term market challenges and deliver an improved performance in the second half. We have delivered group results in line with expectations, which Soraya will talk about in more detail. Smokeless accounts for 17.5% of group revenue, up 1 percentage point versus last year. We added 3.6 million smokeless consumers, reaching 29.1 million, mainly driven by our continued success in Modern Oral. Our focus on quality growth, balancing top and bottom line delivery, has driven a further improvement in new category contribution, up GBP251 million and a 7 percentage point increase in our category contribution margin on an organic constant rates basis. We are committed to rewarding shareholders with strong cash returns, and I'm pleased with our progress improving financial flexibility. Enabling the initiation of sustainable share buyback, continued progress on the leverage to within our target range at 2.4 times, alongside our progressive dividend with 2% growth announced today. Our foundations are solid, and I'm confident that the choices we have made and the actions we have taken through our investment year are the right way forward for BAT. I have been clear that we needed to invest to strengthen our U.S. business, accelerate innovation momentum, and enhance capabilities that support our strategic delivery. While there is more to do, we are making clear progress. Our previously announced commercial plans in the U.S. are completed, and I'm encouraged that our performance accelerated in the second half. Through our improved innovation ecosystem, our new category growth accelerated in the second half, driven by Glo, Hyper Pro, and our refreshed Velo Mix in the U.S. Furthermore, we are excited about the Q4 launchings of our latest innovations, including Velo Plus. As previously highlighted, we do not expect the journey ahead to be linear. We will share more detail on the key drivers and assumptions behind our 2025 guidance later in the presentation. We remain committed to returning to 3% to 5% revenue and 4% to 6% APFO growth adjusted for Canada at constant rates in 2026. And with that, I will hand over to Soraya to take you through our results in more detail.
Thank you, Tadeu, and good morning, everyone. Before diving into the results and to set the context, I would like to remind you of my key focus areas. The first is to fuel our transformation by maximizing sustainable value from combustibles. The second is to drive quality growth in new categories by investing capital in a disciplined manner, targeting the largest profit pools and maintaining a laser focus on returns. The third is to strengthen our financial resilience. And even though we have reached our target debt corridor, including Canada in 2024, by 2026, we aim to be within this corridor, excluding Canada whilst remaining committed to our balanced capital allocation. Now with this in mind, I'd like to share our progress in 2024 as we move to the results. I am pleased to share that we delivered organic constant currency results in line with guidance. Whilst our reported results reflect a number of adjusting items, including our exit from Russia and Belarus, a provision of GBP6.2 billion for Canada's CCAA proposed plan, a charge in Romania and respect of an excise assessment, and the GBP1.6 billion gain due to the partial sale of our ITC investment. To understand the underlying performance, we will focus on organic adjusted constant currency results. More details on adjusting items are in the appendices. So, in line with our guidance, group revenue grew by 1.3%, new category revenue grew by 8.9%, and adjusted operating profit rose 1.4%. And diluted EPS increased by 3.6%. So looking at some of the key drivers, combustibles price makes growth, with pricing up nearly 9% offset by next year. Adjusted gross profit expanded by GBP400 million, supported by revenue growth management and new category scale benefits. Excluding the U.S., we delivered 5.1% revenue growth, and 7.5% operating profit growth. This highlights the strength of our multi-category portfolio and resilience of our global footprint. As expected, new category revenue growth accelerated in the second half. We achieved quality growth with contribution margin rising to 7%. This reflects our targeted investment in high-value profit pools, focused ROI discipline and scaling benefits across markets. I will now provide more details and all shared data is based on full-year averages unless otherwise stated and further information is again available in the appendices. Let's start with Vapor. Vapor is the largest new category globally, with consumer numbers accelerating. While category fundamentals are strong, weak enforcement against illicit single-use vapes in the U.S. and Canada has distorted competition. Vapor revenue fell by 2.5% and growth in Europe, led by views. Go reload was offset by illicit market challenges. Views remains the value share leader, both globally and in the U.S., where we are demonstrating strong financial resilience. U.S. volumes declined by 4%, but they were outperforming the 9% industry decline and track channels. But without stronger enforcement, illicit vapor products will continue to impact the legal market. In AME, we retained value share leadership at 31.5%. Gains in France, Spain and Germany lifted value share by 100 basis points, of course, excluding Canada's losses from Quebec's flavor ban. The UK and in France, however, will likely face short-term disruption from single-use vapor bans in 2025, but we are well positioned for long-term growth. In APMEA, revenue grew 24% driven by strong momentum in South Korea and New Zealand. Moving on to heated products. In heated products, industry growth slowed, impacted by increased new category poly usage in Europe. Glo revenue was up nearly 6%, with a stronger H2 performance as expected. Growth was fueled by the continued rollout of Glo Hyper Pro and improved consumables, moving the brand towards premium positioning. Glo Pro helped improve volume share with a small decline of 40 basis points versus the 110 basis points in 2023. In Japan, Pro consumables gained 110 basis points in volume share, partly offsetting the decline of legacy super slims. In AME, category volume share stabilized with strong gains in Poland and the Czech Republic and continued improvement in Italy. Our tobacco-free range Veo continues to strongly outperform Pears. We have driven a more balanced Glo performance with improved category contribution in 2024, driven by scale benefits and pricing. And last but not least, we move on to Modern Oral, which is the fastest growing new category. Usage and daily consumption are rising in both key and new markets, with non-traditional markets now making up 20% of industry volume. Our revenue grew 53% in Modern Oral in 2024, with strong growth across all regions, improving category contribution. Our category share increased with volume share up 130 basis points. And in AME, we led the Modern Oral category with 65% volume share and Velo captured 70% of category revenue growth. This performance proves Velo is the leading brand and product in the category. In the U.S., our recovery was driven by a refreshed Velo expression and the launch of Grizzly Modern Oral. We gained over two percentage points in volume share, reaching 6.6% and 18% in New York in December, where this mix was first introduced. We expanded our U.S. portfolio with Velo Plus at the end of the year, which Tadeu will discuss later. In combustibles, our volumes declined 5% organically, mainly due to the U.S. market exits and supply chain issues in Sudan also affected performance. Excluding these, volume declined 3.5%. Our volume share grew by 20 basis points, with a strong performance in Brazil, Bangladesh, Mexico, and Pakistan. Value share declined 20 basis points, driven by the U.S. Our U.S. commercial investments in H1 helped recover volume and value share in the second half. Revenue was marginally higher, with growth in AME and APMEA and in APMEA led by Brazil, Japan, and Turkey offsetting the U.S. Now turning to our regions, our U.S. revenue declined by 3.4%, mainly driven by the commercial actions implemented over the last 18 months. In addition to ongoing macroeconomic pressures impacting affordability and illicit vapor products affecting both combustibles and vapor, the combustibles industry declined by around 9% on a sales to retail basis. Excluding deep discount, where we are not present, the industry declined 11% while our volume was down 10.1%. 4% of the industry decline was due to new category poly usage, with illicit vapor contributing 2.5% of this. Our U.S. financial performance improved throughout the year, driven by a strong performance in combustibles versus 2023. Adjusting operating profit fell 3.5% due to lower combustible volume and commercial spending. Tadeu will provide further U.S. updates later. Moving to AME, AME is a multi-category region, with smokeless revenue making up 24% in markets where we are present in new categories. 11 of those markets now generate over 50% of their revenue from smokeless products. Revenue grew nearly 5%, driven by higher combustibles revenue, supported by solid volume and strong pricing, and double-digit new category growth, with Modern Oral up 47%. Vapor revenue declined, mainly due to Canada, and adjusting operating profit rose 7.5%, as scaled benefits in new categories and cost efficiencies offset inflation. In APMEA, growth improved in H2, and smokeless now represents 20% of revenue in markets where we are present with new categories. Total revenue grew by 5.4%, with combustibles up 3.5%, driven by pricing gains, partly offset by the declines in Australia and supply chain disruptions in Sudan. New category revenue grew nearly 9%, led by vapor and Modern Oral gains in emerging markets, and heated products benefiting from innovation and lapping Japan's prior year commercial plans. Adjusted operating profit increased 7.5%, supported by pricing and improved performance in Japan, asset sales, and efficiency gains. Now the group operating margin was flat, as we offset inflation and Forex pressures with higher new category profitability and cost savings. BAT has a strong track record in delivering cost savings. Having achieved close to GBP900 million in savings over the last two years, we are on track to deliver more than GBP1.2 billion by year-end. These savings helped offset inflation and Forex impacts while funding quality growth investments. In 2024 we absorbed GBP390 million in inflationary costs and 1.1% transactional FX headwinds on adjusted operating profit. Inflationary pressures are expected to ease this year. Beyond 2025 we aim to simplify combustibles and drive scale benefits in new categories targeting an additional GBP2 billion in savings by 2030. EPS grew 3.6%. Gains from lower net finance costs and share count were partly offset by our reduced share of ITC profits and tax. The underlying tax rate was 24.9% and we expect around 25% in 2025 based on prevailing rates. Operating cash conversion exceeded 100% for the fifth year reflecting our strong cash discipline. In 2025 we anticipate GBP650 million of gross CapEx and GBP1.8 billion net finance costs adjusted for Canada. Our debt profile is strong with 87% of our net debt fixed with average maturity of just under 10 years and close currency matching. We reduced leverage to 2.4 times which adjusted for Canada would be 2.75 times. We expect to be back within our target leverage range of 2 to 2.5 times post-court approval and implementation of the proposed plans by the end of 2026. We support the proposed CCAA settlement which maximizes value for claimants while securing our continued operation in Canada. In accounting for the proposed settlement we will continue to fully consolidate our Canadian business in accordance with IFRS. We have recognized a GBP6.2 billion provision in our 2024 reported results and this is treated as an adjusting item in line with our accounting policies. In order to ensure that the P&L reflects the economic delivery from Canada from 2025 we will report APFO adjusted for Canada. Now due to the uncertainty of the timing of the settlement in 2025 our non-GAAP reported numbers will remove 100% of our Canadian business excluding new categories with 2024 comparators provided on the same basis in the appendices. It is important to note that we will continue to fully consolidate our revenue in Canada. Subject to the settlement conclusion in 2025. From 2026 we will adjust to remove 85% of our Canadian APFO in line with the charging schedule excluding new categories which we will reduce to 80%, 5 years post-settlement and 75% 10 years post-settlement. After six years in CCAA protection we are pleased to have reached this stage and our accounting treatment set out today is based on the current status of the proposed plan. We are hopeful for a swift resolution and remain committed to our capital allocation priorities. BAT is a highly cash-generative company and we are expecting to over GBP50 billion of free cash flow between 2024 and 2030. We remain committed to our capital allocation priorities of firstly reinvesting in our transformation whilst balancing deleveraging and progressive dividends and sustainable share buybacks and selective bolt-on M&A to accelerate our transformation. Looking ahead we expect significant headwinds in Bangladesh and Australia. In January the interim government in Bangladesh increased VAT and supplementary duty on over 100 essential products including tobacco. Excise has risen sharply coupled with above inflationary floor price increases across all categories which is expected to accelerate illicit trade. In Australia, new tobacco regulations representing the biggest reform since plain packaging in 2012 will come into effect from April 1. In addition, recent ad hoc excise increases most recently last September are already accelerating industry volume decline. Last year illicit trade was up 6 percentage points to 36% of industry volume while smoking incidence has remained stable for the last five years. Combined with a vapor incidence which is currently at nine percent this means that around 65% of nicotine usage in Australia is illicit. Looking forward we expect this ineffective government policy to further accelerate legal industry volume decline and coupled with the announced incremental impact of another excise increase in September to continue to significantly fuel illicit trade. Together we expect these two headwinds both in Australia and in Bangladesh to impact our 2025 group revenue growth by 1% and group APFO growth by close to 2% with the January budget in Bangladesh being the main driver of change since our December trading update. As a result and including these impacts in 2025 we expect to deliver revenue growth of around 1% supporting APFO growth of 1.5% to 2.5% adjusted for Canada and including a 1.5% transactional FX headwind. The key drivers are an improving U.S. financial performance returning to growth despite continued macro and illicit trade headwinds another solid AME performance and further strong growth from Velo globally. Alongside the expected launch of exciting innovations for all three new categories throughout the year we expect to grow APFO ahead of revenue supported by continued strong new category growth contribution and the laser focus on ROI and further cost savings. We expect our group performance to be second half weighted for both revenue and profit as we deploy our new category innovations throughout the year, with our first half performance reflecting progress in the U.S. driven by combustibles and Modern Oral offset by combustible headwinds as described in APMEA and the continued lack of enforcement in the U.S. and Canada together with the Mexico vapor ban. As highlighted at our Capital Markets Day we will continue to track key KPIs across all pillars to measure our transformation success. So in summary 2024 was an investment year and I'm pleased to see our progress reflected in our key metrics. We have deployed dashboards across business units to enhance decision-making. These dashboards focus on our transformation to deliver long-term growth return on investment to ensure financial discipline and cash flow and leverage to maintain financial strength. I am confident these metrics will help us create a sustainable shareholder value. And with that I'll hand it back to Tadeu.
Thank you, Soraya. I would now like to outline the pathway ahead. BAT is transforming with our multi-category strategy and global presence, putting us in a strong position in a growing industry. I believe we have the right strategy, capabilities, and people to achieve a profitable transformation while yielding strong returns to shareholders and advancing our vision of a smokeless world. At our Capital Market Day in October, I shared ten key reasons why I believe in BAT's future growth prospects. Many broader themes have been addressed by Soraya, and I'd like to provide additional insights on our confidence in six key areas highlighted in the slides. First, BAT is well-positioned within the nicotine industry's value, which is growing rapidly as consumers globally shift to new categories. Second, we have completely transformed our innovation ecosystem, enabling us to significantly enhance our product portfolio based on consumer insights. We have an exciting innovation pipeline across new categories that we will launch strategically through 2025. As noted at our CMD, Glo Hilo is an innovative system that we believe will change Glo's positioning in the category, allowing us to compete effectively in the premium segment, which represents over 80% of the industry value. We launched our first two-piece premium device in Serbia in November, and we are gathering insights that are encouraging based on the market response so far. Hilo and our new consumables, Vivto and Rebo, are resonating well with many consumers new to the Glo brand. We will continue to update you as we roll out this exciting platform starting mid-2025. In the vapor sector, Views Ultra will be our initial offering of premium vapor products, representing an untapped opportunity that currently accounts for just 3% of vapor category value. Views Ultra provides a high-quality and satisfying experience for vapor consumers and establishes Views as a trusted brand. Our targeted rollout plans will begin this quarter in Canada and will continue throughout the year. The Modern Oral category in the U.S. is also growing strongly, and I am pleased with our existing portfolio's progress, as noted by Soraya. Looking ahead, I'm excited about our expansion with Velo Plus, launched at the end of last year in seven flavors and two nicotine strengths. Velo Plus is a higher moisture product, and we are seeing very promising early results, including strong consumer demand and trial, with our total volume share in Modern Oral above 10% in the latest readings. We will continue the rollout in the first half of the year with a comprehensive activation plan across retail, media, and digital platforms. My next point of confidence is justified by our business growth in Europe, where over a third of total nicotine consumers are actively using new categories. Our quality growth focus has made new categories pivotal for our success in Europe, as shown in these charts. The growth of new categories has not only allowed our European business to exceed mid-term revenue guidance but has also significantly improved absolute category contribution through scale and efficiencies. The next reason to believe is our U.S. business, which remains essential to our future. As we emphasized at our CMD, one-third of the global adult nicotine value pool is located here, with the industry continuing to grow rapidly. I am encouraged that our investment strategy over the past 18 months is yielding results. In combustibles, we have expanded our distribution coverage to 88%, resulting in a 3.2 percentage point increase in volume share at these newly contracted outlets, with share gains across our brands. This has also led to a 1.2 percentage point decline in the deeper discount segment in these outlets. In the premium segment, we have invested in Newport soft pack in key states, establishing a diverse portfolio. Alongside this, we have consistently gained value share in both the premium segment with Natural American Spirit and in the branded value segment with Lucky Strike, which is the fastest-growing cigarette brand in the market. A key characteristic of our industry recently has been the strength of the deep discount segment, as consumers look to stretch their budgets. In 2024, we have observed a slowdown in deep discount volume growth. However, the branded value segment has increased its volume share, with BAT expanding its segment share, primarily through Lucky Strike. While lower-end adult consumers remain under pressure, we believe these segment dynamics, along with improved consumer confidence levels, indicate early signs of recovery, which would provide momentum in the medium term. To have a clearer view of market performance, we are transitioning to a retail sales data share rate with improved coverage, enhancing our decision quality and speed, which we anticipate will bolster our execution. We are beginning to see returns from our previously planned investments in the U.S. as we strive for value creation. Our total volume share stabilized in 2024. Excluding the deep discount segment where we do not operate, we grew volume share by 40 basis points. Notably, 95% of the U.S. combustibles value pool lies outside the deep discount segment, and we believe we are turning a significant corner with the U.S. returning to growth, which should positively impact our group performance in 2025 and 2026. Regarding regulation, we are encouraged by the withdrawal of a potential menthol ban and the suspension of prior rulemaking as the new administration reconsiders proposed regulations, including very low nicotine. Our success in Europe illustrates our ability to compete effectively in a fair regulatory environment. We continue to advocate for reasonable regulation enforcement in the U.S., particularly in vapor. In 2024, there was an increase in FDA enforcement action. However, the success of legal products relies on the FDA stepping up efforts against illicit vapor. To assist in this, we continue to push for the release of a PMTA list, which would clarify for all market participants. Moreover, the U.S. International Trade Commission is investigating our patent infringement complaint regarding illicit products. At the state level, vapor directory or enforcement legislation has been enacted in 14 states, meaning that approximately 30% of tracked vapor industry volume will be covered by state directories by year-end. Louisiana serves as a strong example of effective regulation paired with proper enforcement; since implementation, the legal vapor market has experienced a volume growth of 33%, alongside a 91% reduction in single-use illicit products in tracked channels. [Indiscernible] has managed to capture the majority of the volume returning to the legal market. Nationally, however, illicit vapor products continue to affect the legal market. Last year's trend of decline in the legal industry has accelerated, and we expect this to persist in 2025. While we hope that government engagement will foster a more equitable playing field over time, we do not anticipate a significant impact on our near-term performance. Effective regulation enforcement is a priority not just in the U.S. We have substantial expertise and capabilities in this area, developed over decades, connecting science, corporate interests, and regulatory affairs to promote a sustainable future. We have created Omni to consolidate scientific evidence and influence broader stakeholder perceptions regarding tobacco harm reduction. We strongly advocate for regulators to embrace tobacco harm reduction, guided by science and supported by robust enforcement to expedite smoking prevalence reduction. Regulators that do not engage in these efforts will not only impede necessary societal transformation but will also see rapid growth in illegal products. Leveraging science and the Omni platform, we are pursuing a more proactive regulatory engagement strategy with encouraging progress in some areas and will continue to amplify our message. Since my appointment as Chief Executive, I have emphasized that by building on our foundations of integrity, collaboration, and inclusivity, we will foster the culture necessary to transform BAT successfully. Guided by our 2030 people strategy, we are already experiencing significant progress. We have a highly engaged and committed workforce, and our updated values resonate well. Our employer value proposition is attracting talent, and we are advancing our diversity and inclusion agenda, all aimed at driving a cultural transformation for a better tomorrow. Before we conclude, I want to highlight our priorities for 2025. Our first priority is our focus on quality growth to ensure that we roll out new innovations strategically, balancing top and bottom-line results. We are committed to generating value from our combustible business, which is critical for funding our transformation, with the U.S. being a significant contributor. We will enhance our proactive approach to regulatory affairs, supported by science and the Omni platform. All these efforts will be executed with a focus on returns in terms of cash generation and maintaining a track record of successful delivery. In 2025, I am confident we will build on our foundations. As Soraya pointed out, our 2025 guidance incorporates notable combustible headwinds in Bangladesh and Australia, amounting to a 1% impact on group revenue and nearly 2% on group EPFO, which is already reflected in our guidance. Looking ahead to 2026, I am optimistic that we can leverage the underlying momentum from 2025 to achieve 3% to 5% revenue growth and 4% to 6% EPFO growth, adjusted for Canada on a constant currency basis. The primary drivers will include improved financial performance in the U.S., aided by a less negative industry volume backdrop, the macro environment, and stronger enforcement against illicit vapor. Additionally, we will focus on quality growth driven by innovations in new categories, overcoming the 2025 combustibles headwinds in Bangladesh, and enhancing efficiencies through our GBP2 billion savings program through 2030. While we have more to accomplish, I am confident that we possess the right strategy, capabilities, and personnel to execute a profitable transformation. I am excited about BAT's future, and I believe we will achieve long-term sustainable growth and value for all our stakeholders. Thank you for your attention. We will now be joined by Victoria for the question and answer session. Victoria?
Thank you, Tadeu and Soraya, and good morning, everyone. Tadeu and Soraya will be happy to take your questions, and I will now hand over to the conference call operator.
Questions and answers
Thank you very much, Victoria. Today's very first question is coming from Faham Baig of UBS. Please go ahead. Your line is open.
Good morning, guys. Thank you for taking my questions. I may take the liberty of three, please. Two clarification ones. I want to start with the U.S., please. I think you mentioned twice in your remarks that you expect a recovery in the U.S. financial performance and a return to growth despite continuing to assume a challenging environment from a macro perspective and illicit vape enforcement. So could you maybe clarify some of the factors that will result in the U.S. growing, and I presume that means revenue growth and profit growth. I'd like to start there.
Yeah, you are right, Faham. Our expectation is that the U.S. goes back to growth. We have three difficult years in combustible since 2022, 2023, 2024. The last two years have been basically an investment year for us to get back where we should. We fixed and invested in a number of areas that I described in my presentation. Obviously, we'll be lapping a lower base in 2024. This is one of the reasons why we will be having the comparator will be a lower base in '24. And also, we'll be building on the positions that I just show in terms of where we stand in terms of market share. We have great momentum behind the Lucky Strike brand, but also Newport has stabilized. And now, with all the lettering that we have done. And we believe that with the expansion in the trade coverage that I refer to, plus capabilities on the digital side that we have been investing, we have more of an expectation that we'll be back in positive territory in 2025. On the new categories, obviously, Velo Plus is doing extremely well. And as I mentioned, this will be very supportive of the progress in the categories in the U.S. The concern we have, as I described it, is that we are not expecting major change in terms of the dynamic of the legal vapor market. This will be a headwind in 2025 that we hope we can cover through the new categories specifically. So overall, we expect the U.S. to be back on growth from 2025 onwards.
Thanks, Tadeu. And maybe I'd like to spend a bit of time on Velo Plus. Could you clarify that volume share for Velo was 10% in the latest reading? And what would that number be for, I guess, just Velo? And maybe if you could share some insights into where we are on distribution for this product? Where do we expect it to go? Where are we on capacity? And I'd like to get your view on how you view moist and wet pouches versus the existing dry offerings in the U.S. What type of consumers is it attracting? And do you think the U.S. consumer is willing to switch from dry to wet?
Out of the above 10%, slightly above 10% that I was referring from the latest reading, Velo Plus accounts for something close to 7%, 7% of this number. The Velo trifecta that is the internal project that we call the refreshed Velo launch last year, accounts for 3%, 3.5%. What we have been seeing in terms of the Velo growth is that no more than 30%, 35% is coming from our previous Velo. So the majority is coming from outside the previous Velo, which in New York, we are getting close now to a 20% reading when you consider both the Velo Plus and the previous one. And obviously, the biggest feature of Velo Plus is the moisture. And we see that this resonates with all types of consumers, because we are using higher moisture outside the U.S. in markets where we have traditional oral, i.e., consumers coming from snus and some other oral products, and consumers that are coming from cigarettes or vapors. So moisture is a key feature and is the main driver behind that. We have now established our presence around 75,000 outlets in the U.S. and we plan to get to 110 outlets from April, actually, which is the second quarter of the year.
Brilliant. That's super clear. And then one question, I guess, probably a clarification. I do want to go back to Bangladesh and this sort of 1 percentage point profit impact that you're facing from Bangladesh. I guess I want to take you back to two years, and I want to take you to Pakistan, where you had, I guess, an even larger excise tax increase, an even larger price increase. Volumes were down 33% in 2023. But your profits, if I'm not mistaken, in local currencies actually grew 33%. So why is Bangladesh different? Why are you anticipating profits to decline in that market with this price increase?
Yeah, let me tell you about Bangladesh. Normally, you see an excise policy every middle of the year, June. So what happened is that the government, in the pressure to raise tax collection, decided to do an ad hoc increase, not just in cigarettes but they increased VAT and duties over 100 products, including cigarettes. And then an excise increase in all tier points, including the above inflation, the floor price. So it's a question of really affordability because consumers were already struggling, as many other consumers in the world, with the cost of living, food price increase, inflation of food prices, and then on top of that had to face 100 products increase in price, and we had to increase across the board the price of cigarettes to cope with those excise increases. Now, this is most of the 1 percent impact. There is also the Australia case that we highlighted. But what we saw, and Pakistan is a good example. When geographies go too far in terms of excise shocks, they will reflect that this is counterintuitive in terms of their desire to increase tax collection, because what happened is exactly the opposite in the second year. After the establishment of a legal market, the government tried to mitigate and take some actions to avoid this from happening. And this is our working assumption for 2026 that we'll be lapping in '25 and not getting even further the impact in '26 related to that, because the government in Bangladesh, 10% of overall tax collection is coming from tobacco, which means that they are very reliant on that. They cannot afford to see the spread of illegal markets across different years. And that's where we talk about the lapping in 2025.
Thank you so much for your questions, Mr. Baig. We'll now move to Rashad Kawan of Morgan Stanley. Please go ahead. Your line is open, sir.
Hey, good morning, guys. Thank you for taking my questions. Two for me, please. So, first one, I know it's still relatively early, but you reiterated getting to your midterm guide by 2026. I guess what gives you confidence in being able to achieve that? How much of an improvement does that assume in U.S. combustibles volumes and enforcement and illicit vapes? And then second question, you talked about sustainable buybacks again today. And again, as you think about 2026, should we assume buybacks will continue irrespective of the Canadian settlement? I know you obviously have some flex from the ITC hotel stake, but potentially could you also look to monetize more of the ITC stake there to fund future buybacks? I guess just any thoughts around how that fits within your capital allocation priorities would be helpful. Thank you.
Okay, thank you for the question. I'm going to leave, sorry, to talk about the capital allocation question. On the 2026, well, we just spoke about Bangladesh, which accounts for most of the 1%. The underlying revenue growth of '25 would have been around 2%, which is pretty much in line with what we have in mind in this journey towards our midterm algorithm in 2026. So like I just explained with our question, we believe that we'll be lapping that in 2025. And the other point is obviously we have invest into a completely reshuffle of our innovation ecosystem during 2024. And the reason why we call 2025 a deployment year is that throughout the year we'll be launching these new initiatives. Glo Hilo, for example, is a very different product than the one that we have currently. So we will increase substantially our competitiveness in tobacco heating products. Velo Plus in the U.S. now complements already a very successful and winning product that we have outside the U.S. in the fastest growing new category in the world today, which is Modern Oral. It's growing in incidence and growing every daily consumption everywhere that we launch this product. And we are clearly a leader in that space. And also vapor, we will be working in terms of establishing a premium, creating actually a premium subcategory within vapor with our new product. So when you come to 2026, you have all these products already in the market. So we will have a full year benefit of those products that will come throughout 2025. So that's another reason. In the U.S., we expect to see a more supportive macroeconomic environment that will resonate better in terms of low-income consumers that have been impacted heavily over the last few years with very high levels of inflation and interest rates. So we expect throughout 2025 to see those macroeconomics be more supportive for the low income. And we really believe that the new administration will try to address a massive problem that we have today in the U.S., which is the proliferation of illegal vapor products that today accounts for more than 7% of the total vapor market in the U.S. because this is really not benefiting anyone. It's not benefiting the U.S. consumer that is not having access to the latest innovative smokeless products. It's not benefiting states that could have been collecting tax. It's not benefiting consumers that don't have access to high-quality products that nobody knows exactly what is in those products, and the legal players because we don't have a level playing field. So I do believe that. Now, obviously, how much of those improvements is that's why we put the range between 3 to 5 revenue, 4 to 6 operating properties, exactly to cope with those ranges. If it's going beyond our expectation, we'll be more in the high end of the range. If it's less of our expectation, we'll be in the lower end of the range. But we'll know more of that as we go along in 2025.
Can I just make an addition? Today, you referred to the revenue impact on 2025, so one percent from Bangladesh and Australia, whereas on APFO, there is a 2% impact. So if you think about that in terms of our 1.5% to 2% guidance, then on an underlying basis, it will be 3.5% to 4.5%. Okay, just taking your question on sustainable buybacks in 2026. As Tadeu mentioned, we will be back to our 3 to 5, 4 to 6 growth algorithm in 2026. And as I mentioned earlier in the presentation, excluding Canada takes us to a leverage of 2.75 times. So looking in terms of capital allocation in 2026, we will aim to get back into our leverage corridor of 2 to 2.5. And we will continue to balance cash returns between basically our progressive dividend policy. We announced 2% this year, and we will continue with this policy because having met a lot of our shareholders, I know how much they value the dividends. But we will also look at, we will be generating enough cash. I think I mentioned in the CMD, once we reach our midterm algorithm, we'll be generating around GBP8 billion of cash per annum. So we'll have sufficient to be able to balance the progressive dividend policy with a sustainable buyback, share buyback. So in answer to your question, yes, we will be looking to maintain. I'll remind you that we've just completed a GBP700 million share buyback, and we are committed to doing the share buyback of GBP900 million this year.
Thank you very much. Very clear.
Thank you, sir. We will now move to Gaurav Jain of Barclays. Please go ahead.
Hi, good morning Tadeu. Good morning. So I have three questions from me as well. So one is, on the ITC hotel stake you own directly 15% I think, of that company. What would be your plans for that?
Okay, as I have referred to in the past, Gaurav, BAT has no interest in becoming a long-term shareholder of a hotel chain in India. And as a consequence, in the right moment that will be decided, where is the best moment to maximize shareholder value? We will be divesting, and we will be using proceeds to make sure that we get to the leverage corridor of 2.5 and 2 by 2026.
Sure, thank you. The second is, just on heated tobacco, and I hear the comments that there's a new platform getting launched this year. But, I mean, I know there was a divestiture of Russia and Ukraine which has reported numbers the way we see it. But if you just look at APMEA numbers which is largely Japan and Korea. It is like flat when competitors have clearly grown much, much higher. So do you believe that you will be able to accelerate this growth to in line with market growth?
Yeah. Yes. What will happen in Japan across 2024, we used to have a legacy system there, which is a super-slim product. And this system got completely replaced by Glo Hyper, basically. And we actually increased price in order to accelerate this migration from the super-slim to the demi-slim, which is the whole Glo Hyper. So as a consequence, you haven't seen much difference in terms of the volumes, the revenue increase. But at the end, we know that Glo Hyper Pro is a much more attractive platform than the previous super-slim that we used to have. They have a higher retention, they have average daily consumption, which is higher and resonates in terms of brand attributes with consumers in a much better way than the previous one. So that's basically the story in Japan in 2024 in Hyper. And this has impacted the whole region performance because most of the HP in the region is coming from Japan. And obviously, with the Glo Hilo, as we said, this is not happening until middle of the year. But in the second half of the year, we expect to complement the offer that we have today with a much more improved and our expectations that we're going to be in a much better position to make better inroads in terms of category share of the tobacco heating products.
Sure. And my last question is on the U.S. So this year, in FY’24, your revenue declined 3.5%. And your cigarette volume is down 10%, your revenue is down 4%, so your price is clearly lagged what the industry leader there was taking. So when you are saying that FY’25 U.S. revenues will be flat, it's more or less that now the pricing on combustibles will start aligning with the industry leader. Is that how I should think about it?
Well, we cannot talk about pricing, Gaurav. But like I said before, we'll be left with a weaker comparator because we had to make the investments that we referred to and we had to ladder the brands to make them more adapted to the reality of the U.S. consumer. And this all has an implication in terms of the top line of the company. But the important thing is that all these initiatives now have been concluded, and then we start in 2025 with a different dynamic.
Thank you, it's clearly a new thought policy that we are seeing in real life. And unfortunately, in this case, I think Australia has become one of these outliers in the world. Like we said today, 65% of nicotine consumption is already legal in Australia. You can count on a handful of fingers what are the counts that you can find in this type of very, very extreme case? And we hope that this will be at a certain point recognized by the authorities and they can make something about that. Because at the end of the day, it's not just about tax collection that's reduced dramatically, but also we know that these illegal activities always come together with other criminal activities. And on top of that, for example, what's happening in vaporware, basically 100% is illegal. It will lose completely control in terms of access to youth, in terms of what consumers are consuming, because these products are completely with a very doubtful type of quality standards. So we hope that the government will wake up for that and take some action related to that. And that's the reason why we are still supportive of the country, of our people there. Obviously, it's still profitable. Otherwise, we wouldn't have had this impact in our numbers in 2025. But the reality is that we are in the hope that these things can change as soon as they can understand what the reality is.
Okay, thank you very much.
Thank you for your question, sir. We'll now move to Damian McNeela of Deutsche Numis. Please go ahead.
Hi, morning, Tadeu. Morning, Soraya. I know we've had a couple of questions already on the U.S., but I just wanted to clarify. Because I think some of the things that need to go better for you in the U.S. are a function of things that are outside of your control, like U.S. consumer and illicit trade. I just wanted to clarify, in your FY’26 return to the growth algo, at the bottom end of the range, that's been driven by everything that you can control in the U.S., but at the top end of the range, that would benefit from things that are outside of your control, is the first question. Second question is on, can you provide any quantitative or qualitative data around what drove the improvement in new category profit contribution in the period by sort of subcategory, please? They're my two questions.
Yeah, thank you. Look, the first question doesn't work precisely like that, but I was trying to articulate in line with what you are just describing. And our numbers in 2026 will be easily within the range or at the top of the range, if we see a proper meaningful enforcement on the vapor business, for example, and improvement in the macroeconomics. But like I said, we are already expecting 2025 for the U.S. to be turned into the corner, into a more supportive business for the rest of BAT. So we believe that we can deliver the range of 3 to 5, 4 to 6 in '26, and we expect that if we are surprised for better enforcement, better macroeconomics than we have in our plans, that we actually could be more in the upper side of the range. You want to take the –
Yes, in terms of the improvement on the new category profitability, if we look at the main drivers, firstly, we've supported the top line with RGM going forward. And also we've been able to optimize our cost of sales by driving scale. And as a result, you'll see in the results that we've actually accreted our gross margin in new categories by 500 basis points. Further down, getting to contribution, we've also been able to work on our return on investment by focusing on the largest profit pools, so reallocation of resources on the largest profit pools, but also we've been driving throughout the business, across all the business unit, dashboards with data analytics to support decision-making and a marketing spend effectiveness program which we've begun to roll out. And hopefully throughout this year we'll roll out throughout the group. And that's really been supporting the delivery and contribution. As you all have seen, we've delivered over GBP250 million in category contribution. We're up to 7%, and there's a lot more to come. We'll continue on this trajectory enhancing contribution. If I had to highlight some of the categories, I think in HP, in tobacco heating products, we drove particularly a better contribution there through RGM, as I said, supporting the top line and taking some pricing, but also reducing losses on devices and benefiting from scale. Modern Oral, as you know, is a highly profitable category, and vaping we continue to work on the profitability by focusing on the premium side of vaping whilst we roll out our innovations going forward.
Very clear. Thank you very much.
Thank you, Damian. Ladies and gentlemen, today's last audio questions or people to have dialed in from the phone will be coming from Richard Felton of Goldman Sachs. Please go ahead.
Thank you very much. Good morning, guys. Three questions for me, please. The first one is on the illicit vapor category outside of the U.S. I'd be interested to know any thoughts or observations on what you're seeing across your markets in terms of the growth of illicit vape. I know there's a lot of attention on the U.S., but are there any other markets which are following a similar pattern, and does that have any implications for your appetite to invest in that category? Second question, is there anything on your guidance in terms of phasing that you can call out? I know in the statement you say second half weighted, but is there any quantification that you can provide around that? And then the third one, apologies if I've missed it, but could you just remind us what the new tobacco regulation actually is in Australia? Thank you.
The illicit vapor category presents significant challenges in the U.S. and Canada, particularly with Canada's recent flavor ban in Quebec, which lacks enforcement. Similarly, the U.S. is facing a surge of illegal products that flood the market with a variety of flavors and unregulated quality. In contrast, countries like France have more control over vapor sales through licensed retailers, which is why we advocate for a retail license approach in the UK, hoping the government will consider this in upcoming legislation. New Zealand has effectively managed the vapor market, leading to a decrease in cigarette usage and a controlled rise in vaping. However, Australia's situation is troubling, with 100% of vapor consumption being illegal despite a substantial portion of the population engaging in it. Malaysia also faces challenges due to a lack of enforcement after opening the market. Despite these issues, the vapor category remains the largest and most promising for converting smokers to lower-risk alternatives. It's important to establish proper regulations and enforcement, which we are pushing for across various jurisdictions. Positive developments, like Chile approving vapor sales soon, highlight the potential for substantial public health benefits. Regarding your question about the second half of the year, we anticipate benefiting from new product launches in that timeframe. For instance, Glo Hilo represents our entry into the premium tobacco heating product segment, which will help drive growth. Velo Plus is performing well and will be more established in the market by then. We expect most of our revenue growth to stem from new categories, as noted in our previous remarks. In Australia, new tobacco regulations represent significant changes, including updated health warnings and pack formats, alongside continued tax increases. The illegal market thrives on the absence of these regulations, explaining its growth there. We need to maintain a broad perspective, as while challenges exist, there are many opportunities too. BAT's diverse portfolio across multiple geographies and categories allows us to mitigate regional pressures. For example, during COVID, while certain regions struggled, strong performance in the U.S. helped stabilize the company. Currently, as new categories compensate for declines in combustibles, we are adapting effectively. Our outlook for 2024 and transition into 2025 looks promising, with hopes of reaching solid ground by 2026. As for Canada, we aim to define its status soon, acknowledging the complexities of IFRS regulations. We may proceed with consolidating Canada in 2025 if a resolution appears likely. We previously faced doubts about profitability in new categories, yet we've made significant progress from a substantial loss to achieving a 7% operating margin in four years. We've developed leading products in Modern Oral and improved our tobacco heating product line, positioning ourselves favorably for the future. Lastly, while leverage has been a past concern, we've shown our ability to meet financial targets. It's crucial to maintain a holistic view of our situation, as this perspective matters greatly for navigating future challenges and opportunities.
Thank you, Tadeu. I'm afraid that's all we have time for today. If your question hasn't been answered, then please don't hesitate to contact the IR team and we will help you directly. But I'd like to hand back to Tadeu for some closing remarks.
Thank you all for listening today and for your questions. To close, I'm pleased that we have delivered 2024 results in line with expectations. While there is still more to do, I'm confident the investment actions we have taken are the right way forward for BAT as we build our momentum through 2025 to deliver our medium-term algorithm in 2026. We will continue to reward our shareholders through strong cash returns, including our progressive dividend and sustainable share buyback, and build on our foundations to deliver long-term growth and value creation. Thank you again for joining us and I look forward to updating you on our progress at our half-year results.